Results from first 59 leukemia patients who received investigational, personalized cellular therapy

Three and a half years after beginning a clinical trial that demonstrated the first successful and sustained use of genetically engineered T cells to fight leukemia, a research team will today announce the latest results of studies involving both adults and children with advanced blood cancers that have failed to respond to standard therapies.

Read the whole article on Science Daily

More from Science Daily